UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INSM — INSMED Inc
CIK 861177
NEW YORK, NY
Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$142,345,265
-$56,335,618 QoQ
Shares Held
1,335,071
+9.9% QoQ
Ownership
0.611%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#32
of 663 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. INSM ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
This page
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in INSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,345,265 | 1,335,071 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $198,680,883 | 1,215,025 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $164,172,971 | 943,306 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $73,840,978 | 512,749 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,041,508 | 695,961 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $41,157,230 | 539,484 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $33,611,910 | 486,847 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,874,328 | 422,936 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,296,085 | 437,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,042,584 | 407,025 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,630,592 | 407,570 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,181,654 | 363,630 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,443,190 | 352,758 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,014,520 | 352,758 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,100,349 | 355,373 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,078,688 | 328,630 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,902,927 | 451,467 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,785,441 | 458,955 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,510,960 | 128,890 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,178,113 | 115,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,500,577 | 123,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,964,718 | 116,404 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,791,828 | 113,903 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $3,330,859 | 103,636 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,913,757 | 105,801 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,605,531 | 100,158 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||